Vitiligo researchVitiligo Scientific Study 4 January 2023 Approaching Nonsegmental Vitiligo with a Focus on the Immune-Mediated Aspects of the Disease and a New Treatment Option to Consider Managing vitiligo has been a challenging journey. There have been… VIPOC 0 Love0
Vitiligo researchVitiligo Scientific Study 2 December 2022 The Genetic Basis of Vitiligo Vitiligo is a complex disease in which autoimmune destruction of… VIPOC 0 Love0
Vitiligo researchVitiligo Scientific Study 28 October 2022 Translational Research in Vitiligo Erica L. Katz and John E. Harris Vitiligo is a… VIPOC 0 Love0
Covid and vaccinationVitiligo Scientific Study 13 September 2022 COVID‐19 and autoimmune phenomena: Vitiligo after Astrazeneca vaccine by Irene López Riquelme, 1 María Dolores Fernández Ballesteros, 1 Ana Serrano Ordoñez, 1 and Daniel Jesús… VIPOC 0 Love0
Vitiligo researchVitiligo Scientific Study 27 July 2022 FDA Approves New Vitiligo Treatment, Ruxolitinib (Opzelura) The JAK inhibitor cream is the first medication that can restore pigment in people with this autoimmune disease. By Becky Upham July 22, 2022 On July 18, the… VIPOC 0 Love0
VitiligoVitiligo researchVitiligo Scientific Studyvitiligo treatment 12 April 2022 Factors affecting quality of life in patients with vitiligo Part 2 Patients and methods Participants and settings A nationwide questionnaire-based study… VIPOC 0 Love0
Quality of Life with VitiligoVitiligoVitiligo researchVitiligo Scientific Studyvitiligo treatment 18 March 2022 Anxiety and depression in pediatric patients with vitiligo and alopecia areata and their parents: A cross-sectional controlled study Part 1 Department of Dermatology, University of Health Sciences, Sultan Abdulhamid Han… VIPOC 0 Love0